Antihypertensive Drugs and Lip Cancer in Non-Hispanic Whites | Zendy

Gary Friedman | Zendy; Maryam M. Asgari | Zendy; E. Margaret Warton | Zendy; James Chan | Zendy; Laurel A. Habel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antihypertensive Drugs and Lip Cancer in Non-Hispanic Whites

Author(s) -

Gary Friedman,

Maryam M. Asgari,

E. Margaret Warton,

James Chan,

Laurel A. Habel

Publication year - 2012

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2012.2754

Subject(s) - hydrochlorothiazide , atenolol , medicine , lisinopril , nifedipine , odds ratio , triamterene , diuretic , cancer , antihypertensive drug , pharmacology , endocrinology , blood pressure , angiotensin converting enzyme , calcium

In screening pharmaceuticals for possible carcinogenic effects we noted an association between lip cancer risk and the photosensitizing antihypertensive drugs hydrochlorothiazide and nifedipine. In this study, we further characterized the risk of lip cancer associated with these and other commonly used antihypertensive drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research